Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05144685 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic
A Phase 2 study, sponsored by Oui Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 356
- Enrollment target
NCT05144685: Clinical Trial Phase 2 study, sponsored by Oui Therapeutics.
NCT05144685 is a Phase 2 study that was terminated before completion, run by Oui Therapeutics. The registered enrollment target is 356 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (168% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05144685, a Phase 2 study, was terminated before completion, sponsored by Oui Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 356 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the effectiveness of a digital intervention in reducing suicide attempts.
Primary Outcome
The C-SSRS will be used to assess change in suicide behaviors at 8 separate time points from screening period to Week 104.
Interventions
- BEHAVIORAL Treatment as Usual
- DEVICE OTX-202
- DEVICE OTX-000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2022-04-07 |
| Est. Completion | 2024-06-14 |
| Phase | Phase 2 |
Why NCT05144685 stopped before completion
NCT05144685 is an interventional study that assigns participants to a tested intervention. The registered 356 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (168% higher).
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT05144685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05144685 about?
NCT05144685 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic". The primary objective of this study is to assess the effectiveness of a digital intervention in reducing suicide attempts.
What is the current status of trial NCT05144685?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 356 participants. The study started on 2022-04-07. Estimated completion is 2024-06-14.
What interventions are being tested in trial NCT05144685?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), OTX-202 (DEVICE), OTX-000 (DEVICE).
Who is sponsoring clinical trial NCT05144685?
This trial is sponsored by Oui Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05144685's enrollment target sits among peer trials
356 128th of 2000 higher than 1,873 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
- NCT06958328 · 356 participants · Phase 3
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- NCT06960993 · 356 participants · NA
Mosaic Trial for Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI